The patient health questionnaire-9: validation among patients with glaucoma.

BACKGROUND: Depression and anxiety are two common normal responses to a chronic disease such as glaucoma. This study analysed the measurement properties of the depression screening instrument - Patient Health Questionnaire-9 (PHQ-9) using Rasch analysis to determine if it can be used as a measure. M...

Full description

Bibliographic Details
Main Authors: Vijaya K Gothwal, Deepak K Bagga, Seelam Bharani, Rebecca Sumalini, Shailaja P Reddy
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4085058?pdf=render
id doaj-6b9a1186101f44849ced2a14f22cd361
record_format Article
spelling doaj-6b9a1186101f44849ced2a14f22cd3612020-11-25T01:18:39ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0197e10129510.1371/journal.pone.0101295The patient health questionnaire-9: validation among patients with glaucoma.Vijaya K GothwalDeepak K BaggaSeelam BharaniRebecca SumaliniShailaja P ReddyBACKGROUND: Depression and anxiety are two common normal responses to a chronic disease such as glaucoma. This study analysed the measurement properties of the depression screening instrument - Patient Health Questionnaire-9 (PHQ-9) using Rasch analysis to determine if it can be used as a measure. METHODS: In this hospital-based cross-sectional study, the PHQ-9 was administered to primary glaucoma adults attending a glaucoma clinic of a tertiary eye care centre, South India. All patients underwent a comprehensive clinical evaluation. Patient demographics and sub-type of glaucoma were abstracted from the medical record. Rasch analysis was used to investigate the following properties of the PHQ-9: behaviour of the response categories, measurement precision (assessed using person separation reliability, PSR; minimum recommended value 0.80), unidimensionality (assessed using item fit [0.7-1.3] and principal components analysis of residuals), and targeting. RESULTS: 198 patients (mean age ± standard deviation  = 59.83±12.34 years; 67% male) were included. The native PHQ-9 did not fit the Rasch model. The response categories showed disordered thresholds which became ordered after category reorganization. Measurement precision was below acceptable limits (0.62) and targeting was sub-optimal (-1.27 logits). Four items misfit that were deleted iteratively following which a set of five items fit the Rasch model. However measurement precision failed to improve and targeting worsened further (-1.62 logits). CONCLUSIONS: The PHQ-9, in its present form, provides suboptimal assessment of depression in patients with glaucoma in India. Therefore, there is a need to develop a new depression instrument for our glaucoma population. A superior strategy would be to use the item bank for depression but this will also need to be validated in glaucoma patients before deciding its utility.http://europepmc.org/articles/PMC4085058?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Vijaya K Gothwal
Deepak K Bagga
Seelam Bharani
Rebecca Sumalini
Shailaja P Reddy
spellingShingle Vijaya K Gothwal
Deepak K Bagga
Seelam Bharani
Rebecca Sumalini
Shailaja P Reddy
The patient health questionnaire-9: validation among patients with glaucoma.
PLoS ONE
author_facet Vijaya K Gothwal
Deepak K Bagga
Seelam Bharani
Rebecca Sumalini
Shailaja P Reddy
author_sort Vijaya K Gothwal
title The patient health questionnaire-9: validation among patients with glaucoma.
title_short The patient health questionnaire-9: validation among patients with glaucoma.
title_full The patient health questionnaire-9: validation among patients with glaucoma.
title_fullStr The patient health questionnaire-9: validation among patients with glaucoma.
title_full_unstemmed The patient health questionnaire-9: validation among patients with glaucoma.
title_sort patient health questionnaire-9: validation among patients with glaucoma.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description BACKGROUND: Depression and anxiety are two common normal responses to a chronic disease such as glaucoma. This study analysed the measurement properties of the depression screening instrument - Patient Health Questionnaire-9 (PHQ-9) using Rasch analysis to determine if it can be used as a measure. METHODS: In this hospital-based cross-sectional study, the PHQ-9 was administered to primary glaucoma adults attending a glaucoma clinic of a tertiary eye care centre, South India. All patients underwent a comprehensive clinical evaluation. Patient demographics and sub-type of glaucoma were abstracted from the medical record. Rasch analysis was used to investigate the following properties of the PHQ-9: behaviour of the response categories, measurement precision (assessed using person separation reliability, PSR; minimum recommended value 0.80), unidimensionality (assessed using item fit [0.7-1.3] and principal components analysis of residuals), and targeting. RESULTS: 198 patients (mean age ± standard deviation  = 59.83±12.34 years; 67% male) were included. The native PHQ-9 did not fit the Rasch model. The response categories showed disordered thresholds which became ordered after category reorganization. Measurement precision was below acceptable limits (0.62) and targeting was sub-optimal (-1.27 logits). Four items misfit that were deleted iteratively following which a set of five items fit the Rasch model. However measurement precision failed to improve and targeting worsened further (-1.62 logits). CONCLUSIONS: The PHQ-9, in its present form, provides suboptimal assessment of depression in patients with glaucoma in India. Therefore, there is a need to develop a new depression instrument for our glaucoma population. A superior strategy would be to use the item bank for depression but this will also need to be validated in glaucoma patients before deciding its utility.
url http://europepmc.org/articles/PMC4085058?pdf=render
work_keys_str_mv AT vijayakgothwal thepatienthealthquestionnaire9validationamongpatientswithglaucoma
AT deepakkbagga thepatienthealthquestionnaire9validationamongpatientswithglaucoma
AT seelambharani thepatienthealthquestionnaire9validationamongpatientswithglaucoma
AT rebeccasumalini thepatienthealthquestionnaire9validationamongpatientswithglaucoma
AT shailajapreddy thepatienthealthquestionnaire9validationamongpatientswithglaucoma
AT vijayakgothwal patienthealthquestionnaire9validationamongpatientswithglaucoma
AT deepakkbagga patienthealthquestionnaire9validationamongpatientswithglaucoma
AT seelambharani patienthealthquestionnaire9validationamongpatientswithglaucoma
AT rebeccasumalini patienthealthquestionnaire9validationamongpatientswithglaucoma
AT shailajapreddy patienthealthquestionnaire9validationamongpatientswithglaucoma
_version_ 1725141345563049984